Indication
Rett syndrome
Rett syndrome is a rare, severe neurodevelopmental disorder of the central nervous system that occurs almost exclusively in females and is most often caused by de novo loss-of-function mutations in the X-linked methyl-CpG-binding protein 2 (*MECP2*) gene. Read more about Rett syndrome
2 drugs 1 manufacturers
Drugs that treat it
Common Rett syndrome therapies.
DAYBUE STIX (trofinetide)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRett syndrome is a rare, severe neurodevelopmental disorder of the central nervous system that occurs almost exclusively in females and is most often caused by de novo loss-of-function mutations in the X-linked methyl-CpG-binding protein 2 (*MECP2*) gene.
Following an initial period of apparently normal development during the first 6 to 18 months of life, affected individuals experience early developmental regression marked by the loss of acquired purposeful hand skills and expressive spoken language.
Defining clinical features subsequently include the emergence of stereotypic hand movements, gait ataxia, deceleration of head growth, autonomic breathing irregularities, seizures, and profound cognitive and motor impairment.
- medlineplus.gov
Rett syndrome is a rare, severe neurodevelopmental disorder of the central nervous system that occurs almost exclusively in females and is most often caused by de novo loss-of-function mutations in the X-linked methyl-CpG-binding protein 2 (*MECP2*) gene Following an initial period of apparently normal development during the first 6 to 18 months of life, affected individuals experience early developmental regression marked by the loss of acquired purposeful hand skills and expressive spoken lang...
- medlineplus.gov
Rett syndrome is a rare, severe neurodevelopmental disorder of the central nervous system that occurs almost exclusively in females and is most often caused by de novo loss-of-function mutations in the X-linked methyl-CpG-binding protein 2 (*MECP2*) gene Following an initial period of apparently normal development during the first 6 to 18 months of life, affected individuals experience early developmental regression marked by the loss of acquired purposeful hand skills and expressive spoken lang...
- nih.gov
Rett syndrome is a rare, severe neurodevelopmental disorder of the central nervous system that occurs almost exclusively in females and is most often caused by de novo loss-of-function mutations in the X-linked methyl-CpG-binding protein 2 (*MECP2*) gene Following an initial period of apparently normal development during the first 6 to 18 months of life, affected individuals experience early developmental regression marked by the loss of acquired purposeful hand skills and expressive spoken lang...
Personalize your experience
Follow Rett syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.